Artificial intelligence company twoXAR says first-round financing will also help it build its pipeline and recruit new staff.
The CRO just took in Continuum Clinical’s Late Stage research practice and folded it into its Evidence business unit.
Clinical development has fallen behind in adopting digital technologies. The time for biopharma R&D to act is now.
Citoxlab is looking to boost its position among Europe’s top nonclinical CROs by buying up Solvo Biotechnology.
The CRO will transfer most of its Pennsylvania-based biologics laboratory functions to a new, 73,000-square-foot site on Devon Park in Wayne.
Learn how companies are replacing resource-intensive manual adjudication with innovative new technologies – improving efficiency, data quality, and compliance.
The new team brings together the CRO’s existing expertise in flow cytometry, immunoassays, cell-based assays and immunotoxicology.
Atomwise is the first company to commercialize deep neural networks for drug discovery.
Helix plans to expand its DNA test marketplace this year to offer over 50 products, including launches from companies like Mayo Clinic.
A CAR-T biotech formed by Juno and WuXi got off a $90 million series A with Chinese backing, as it eyes clinical trials of its new cancer therapy.
Sanofi will license out a host of infectious disease assets to Evotec, with 100 staffers also moving into its R&D engine.
Big Pharma Novartis is teaming up with virtual clinical trial company Science 37 to boost the Swiss major’s ability to run “site-less” studies.